Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: AC Immune pops in trading debut

    Neurodegeneration company AC Immune S.A. (NASDAQ:ACIU) gained $4.66 (42%) to $15.66 on Friday in its first day of trading after raising $66 million in an IPO underwritten by Credit Suisse, Jefferies and Leerink (see …

    Published on 9/23/2016
  • FINANCIAL NEWS: iOmx raises EUR 40M series A round

    Immuno-oncology company iOmx Therapeutics AG (Martinsried, Germany) raised EUR 40 million ($44.6 million) in a series A round co-led by MPM Capital and Sofinnova Partners. Other investors included Wellington Partners …

    Published on 9/22/2016
  • FINANCIAL NEWS: Sarepta raises $300M in bumped-up follow-on

    Duchenne muscular dystrophy (DMD) company Sarepta Therapeutics Inc. (NASDAQ:SRPT) raised $300 million through the sale of 5 million shares at $59.75 in a follow-on underwritten by JPMorgan, Goldman Sachs, Credit Suisse,…

    Published on 9/22/2016
  • FINANCIAL NEWS: Artios launches with $33.2M

    Cancer newco Artios Pharma Ltd. (Cambridge, U.K.) raised $33.2 million in a series A round led by SV Life Sciences. Merck Ventures, Imperial Innovations Group plc (LSE:IVO), Arix Bioscience plc, the CRT Pioneer Fund of …

    Published on 9/21/2016
  • FINANCIAL NEWS: Dermatology play Novan raises $45.1M in IPO

    Novan Inc. (NASDAQ:NOVN) gained $7.10 (65%) to $18.10 on its first day of trading Wednesday after raising $45.1 million through the sale of 4.1 million shares at $11 in an IPO. Piper Jaffray, JMP Securities and Wedbush …

    Published on 9/21/2016
  • FINANCIAL NEWS: Medicines Co., Roche land BARDA antibiotics contracts

    HHS's Biomedical Advanced Research and Development Authority (BARDA) signed contracts with The Medicines Co. (NASDAQ:MDCO) and Roche (SIX:ROG; OTCQX:RHHBY) to treat drug-resistant, Gram-negative infections. BARDA will …

    Published on 9/21/2016
  • FINANCIAL NEWS: Cellenkos raises $10M venture round

    The University of Texas MD Anderson Cancer Center and Golden Meditech Ltd. (HKSE:00801; Taiwan:910801) launched immunotherapy newco Cellenkos Inc. (Houston, Texas) with $10 million in a venture round. Golden Meditech …

    Published on 9/20/2016
  • FINANCIAL NEWS: Financial tracks

    Frazier Healthcare Partners hired Amit Jain as an operating partner on its growth buyout team. He was SVP and head of business operations at Omnicare Inc., which CVS Health Corp. (NYSE:CVS) acquired.

    Published on 9/20/2016
  • FINANCIAL NEWS: TenNor raises $25M in series B round

    Antibiotic play TenNor Therapeutics Ltd. (Suzhou, China) raised $25 million in a series B round led by Northern Light Venture Capital. Existing investors Frontline BioVentures, WuXi PharmaTech Healthcare, Oriza Venture …

    Published on 9/19/2016
  • FINANCIAL NEWS: Aerie raises $125M in pair of offerings

    Ophthalmic play Aerie Pharmaceuticals Inc. (NASDAQ:AERI) raised a combined $125 million in a follow-on and at-the-market offering. Cantor Fitzgerald is managing both. The biotech raised $75 million through the sale of 2…

    Published on 9/16/2016
  • FINANCIAL NEWS: Financial tracks

    Hendrik Struik re-joined Frazier Healthcare Partners as an operating partner on its growth buyout team. He was CEO at Laboratory Supply Company Inc., which McKesson Corp. (NYSE:MCK) acquired.

    Published on 9/16/2016
  • FINANCIAL NEWS: Agios raises $150M in follow-on

    Agios Pharmaceuticals Inc. (NASDAQ:AGIO) raised $150 million through the sale of 3.4 million shares at $44.50 in a follow-on underwritten by JPMorgan, Goldman Sachs, and Cowen. The company proposed the offering after …

    Published on 9/15/2016
  • FINANCIAL NEWS: Avalon's eleventh fund grows

    Avalon Ventures has raised a total of $116.5 million toward a planned $300 million eleventh fund, according to a regulatory filing. A September 2015 filing said the firm had raised $103.5 million (see BioCentury Extra, …

    Published on 9/15/2016
  • FINANCIAL NEWS: Cancer company Peloton raises $52.4M

    Peloton Therapeutics Inc. (Dallas, Texas) raised $52.4 million in a series D round. New investor Foresite Capital Management participated, as did all of Peloton's existing investors, including Remeditex, The Column …

    Published on 9/15/2016
  • FINANCIAL NEWS: Cell therapy newco GammaDelta launched

    Immunotherapy newco GammaDelta Therapeutics Ltd. (London, U.K.) raised an undisclosed amount of seed funding from Abingworth. The start-up is developing gamma delta T cell therapies to treat cancer (see BioCentury …

    Published on 9/15/2016
  • FINANCIAL NEWS: Intarcia raises $215M, expects more next quarter

    Diabetes company Intarcia Therapeutics Inc. (Boston, Mass.) raised $215 million in the first close of a series EE round. The company expects to raise more money next quarter in a second, larger close that would bring …

    Published on 9/15/2016
  • FINANCIAL NEWS: Delinia raises $35M series A round

    Autoimmune and inflammatory therapeutics start-up Delinia Inc. (Cambridge, Mass.) raised $35 million in a series A round co-led by Sofinnova Partners and Atlas Venture.Delinia aims to treat autoimmune disorders without …

    Published on 9/14/2016
  • FINANCIAL NEWS: Third Rock launches Relay with $57M series A

    Third Rock Ventures launched Relay Therapeutics Inc. (Cambridge, Mass.) with a $57 million series A round that included participation from D. E. Shaw Research. The biotech's discovery platform is focused on protein …

    Published on 9/14/2016
  • FINANCIAL NEWS: AC Immune sets IPO terms

    AC Immune S.A. (Lausanne, Switzerland) amended its proposed IPO on NASDAQ and now plans to sell 4.5 million shares at $11-$13. At $12, the company would raise $54.5 million and be valued at $647.3 million. Credit Suisse…

    Published on 9/13/2016
  • FINANCIAL NEWS: Gene therapy play BrainVectis raises EUR 1M

    BrainVectis (Fontenay aux Roses, France) raised EUR 1 million ($1.1 million) in a series A round from private investors. The company is developing a gene therapy that delivers cytochrome P450 family 46 subfamily A …

    Published on 9/13/2016
  • FINANCIAL NEWS: Advantagene raises $14.2M

    Immuno-oncology company Advantagene Inc. (Auburndale, Mass.) raised $14.2 million in a series A round from undisclosed investors. The National Securities Corp. subsidiary of National Holdings Corp. (NASDAQ:NHLD) was the…

    Published on 9/12/2016
  • FINANCIAL NEWS: CRISPR Therapeutics files for IPO

    Gene editing company CRISPR Therapeutics AG (Basel, Switzerland) filed to raise up to $90 million in an IPO on NASDAQ underwritten by Citigroup, Piper Jaffray, Barclays and Guggenheim. In June, CRISPR Therapeutics added…

    Published on 9/12/2016
  • FINANCIAL NEWS: Inflazome raises $17M for inflammasome inhibitors

    Inflazome Ltd. (Dublin, Ireland) raised $17 million in a series A round co-led by Novartis Venture Funds and Fountain Healthcare Partners.Inflazome is developing small molecule inflammasome inhibitors to treat chronic …

    Published on 9/12/2016
  • FINANCIAL NEWS: Neuralstem raising $20M from Tianjin

    Neuralstem Inc. (NASDAQ:CUR) is raising $20 million through the sale of shares and convertible stock in a private placement with Tianjin Pharmaceuticals Group Co. Ltd. (Tianjin, China). Neuralstem is selling 28.5 …

    Published on 9/12/2016
  • FINANCIAL NEWS: CoLucid raises $65M in follow-on

    Migraine therapy developer CoLucid Pharmaceuticals Inc. (NASDAQ:CLCD) raised $65 million through the sale of 3.3 million shares at $20 in a follow-on underwritten by Piper Jaffray, Barclays, Stifel and Ladenburg …

    Published on 9/9/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993